In 2010 was created Boyu Capital, which is appeared as VC. The main department of described VC is located in the Beijing. The venture was found in Asia in China.
The standard case for the fund is to invest in rounds with 5-6 partakers. Despite the Boyu Capital, startups are often financed by Tencent Holdings, Morningside Venture Capital, Matrix Partners. The meaningful sponsors for the fund in investment in the same round are Sequoia Capital China, 6 Dimensions Capital, YF Capital (Yunfeng Capital). In the next rounds fund is usually obtained by Temasek Holdings, 6 Dimensions Capital, blisce/.
The typical startup value when the investment from Boyu Capital is more than 1 billion dollars. Comparing to the other companies, this Boyu Capital performs on 13 percentage points less the average number of lead investments. The top amount of exits for fund were in 2019. The usual things for fund are deals in the range of more than 100 millions dollars. Considering the real fund results, this VC is 12 percentage points more often commits exit comparing to other organizations. The top activity for fund was in 2018. The fund is constantly included in 2-6 deals per year.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most successful fund investment fields, there are Health Diagnostics, Financial Services. Among the most popular portfolio startups of the fund, we may highlight Alibaba, iQiyi, LY.com. The fund has exact preference in a number of founders of portfolio startups. If startup sums 4 of the founder, the chance for it to be financed is low.
This organization was formed by Mary Ma. The overall number of key employees were 4.
Related Funds
Funds with similar focus
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Positive Sequence Biology | $15M | 08 Aug 2024 | Shanghai, Shanghai, China | ||
Tai Hydrogen Energy | $23M | 10 Jan 2024 | Shanghai, Shanghai, China | ||
Doujin Culture | $2M | 12 Sep 2023 | Hangzhou, Zhejiang, China | ||
Farizon Auto | $600M | 07 Jul 2023 | Hangzhou, Zhejiang, China | ||
Tianbing Technology | $15M | 06 Jul 2023 | Dongcheng District, Beijing, China | ||
Evat Master | $46M | 01 Jun 2022 | Shenzhen, Guangdong, China | ||
ArriVent Biopharma | $69M | 15 Feb 2022 | Pennsylvania Furnace, Pennsylvania, United States | ||
Positive Sequence Biology | $46M | 08 Nov 2021 | Shanghai, Shanghai, China | ||
Edge Medical Robotics | $200M | 05 Nov 2021 | Futian District, Guangdong Province, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Positive Sequence Biology | $15M | 08 Aug 2024 | Shanghai, Shanghai, China | ||
Tai Hydrogen Energy | $23M | 10 Jan 2024 | Shanghai, Shanghai, China | ||
Doujin Culture | $2M | 12 Sep 2023 | Hangzhou, Zhejiang, China | ||
Farizon Auto | $600M | 07 Jul 2023 | Hangzhou, Zhejiang, China | ||
Tianbing Technology | $15M | 06 Jul 2023 | Dongcheng District, Beijing, China | ||
Evat Master | $46M | 01 Jun 2022 | Shenzhen, Guangdong, China | ||
ArriVent Biopharma | $69M | 15 Feb 2022 | Pennsylvania Furnace, Pennsylvania, United States | ||
Positive Sequence Biology | $46M | 08 Nov 2021 | Shanghai, Shanghai, China | ||
Edge Medical Robotics | $200M | 05 Nov 2021 | Futian District, Guangdong Province, China |